Health & Environmental Research Online (HERO)


Print Feedback Export to File
6322772 
Journal Article 
TARGETING NEWLY IDENTIFIED ER beta/TGF-beta 1/SMAD3 SIGNALS WITH THE FDA-APPROVED ANTI-ESTROGEN FASLODEX OR AN ER beta SELECTIVE ANTAGONIST IN RENAL CELL CARCINOMA 
Song, W; Xu, H; Doersch, KM; Chou, FuJu; He, D; Chen, Y; Hsu, I; Yeh, CRen; Chang, LSS; Li, Lei; Messing, E; Chang, C; Yeh, S 
2019 
Journal of Urology
ISSN: 0022-5347
EISSN: 1527-3792 
201 
E206-E207